Advanced Search


Study ID Status Title Patient Level Data
111000 Completed Experimental medicine study to validate pharmacodynamic pain assessments in healthy volunteers in a randomised, double blind, placebo controlled, 2 way cross-over design with an opioid analgesic (Remifentanil)
111035 Completed A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents Study Listed on
111050 Completed Hospital-based Epidemiological Study on the Distribution of Human Papillomavirus (HPV) Types in Adult Women Diagnosed With Invasive Cervical Cancer (ICC) in New Zealand
111074 Completed A study to collect blood and urine samples in elderly subjects with pneumonia to support the development of bacteriological diagnostic assays
111081 Completed A Multicentre, Single Arm, Observational Phase IV Study to Assess the Safety and Efficacy of Nelarabine in Children and Young Adults (up to 21 Years of Age) with Relapsed or Refractory T-Lineage Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma
111109 Completed An open-label, multicenter, phase I/II study of pazopanib in combination with paclitaxel in first-line treatment of subjects with stage IIIBwet/IV non-small cell lung cancer
111114 Completed A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR DISKUS (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
111116 Completed Prevalence of Chronic Airway Onstruction in a Subject Population with a History of Cigarette Smoking in a Primary care Setting
111117 Completed A Randomized, Double-Blind, Double-Dummy, Parallel Group 12-Week Comparison of the Efficacy and Safety of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler 230/42mcg twice-daily with Fluticasone Propionate/Salmeterol DISKUS 250/50mcg twice-daily in subjects with COPD Study Listed on
111128 Relinquished An open-label, multicentre, randomised phase II study of pazopanib in combination with pemetrexed in first-line treatment of subjects with predominantly non-squamous cell stage IIIB wet/IV non-small cell lung cancer
111149 Completed Evaluate the effect of risk factors that influence the immunogenicity of GSK Biologicals' Twinrix compared to hepatitis A and hepatitis B vaccines given separately and to show the non-inferiority between the vaccines in adults Study Listed on
111155 Completed A double blind, parallel group, placebo controlled study to evaluate the effect of a single oral dose of GSK958108 on ejaculatory latency time (ELT) in male patient suffering from premature ejaculation Study Listed on
111157 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals’ Infanrix hexa™ vaccine in healthy infants in India Study Listed on
111175 Completed A randomized, methodology study to investigate the use of 3He-MRI lung ventilation and proton MRI perfusion imaging to detect changes in ventilation perfusion relationships in Chronic Obstructive Pulmonary Disease (COPD) patients; a proof of concept study.
111187 Completed Randomised, double-blind, placebo-controlled study of topical Clobetasone Butyrate Cream in patients with eczema for two weeks to evaluate the efficacy and safety
111188 Completed Primary vaccination course in healthy children receiving the pneumococcal vaccine GSK 1024850A co-administered with Tritanrix™-HepB/Hib at 6, 10 and 14 weeks of age Study Listed on
111198 Completed Use of Beta-blockers and risk of new onset diabetes
111208 Completed The Combination Product of Sumatriptan and Naproxen Sodium Pharmacy Budget Impact Model database validation study
111258 Completed Observer-blind, Post-Marketing Study to Compare the Safety and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2007-2008 Season) Made With New vs. Aged Bulk Material, in Adults Ranging in Age from 18 to 60 Years Study Listed on
111261 Completed Impact of ADA Treatment Guidelines for Type 2 Diabetes on Adherence and Economic Outcomes: Avandia plus Metformin therapy vs. Sulfonylurea plus Metformin therapy among Persistent Patients
111262 Terminated Resource utilization and costs associated with use of rosiglitazone versus insulin as add-on therapy to metformin users in the Veterans Administration
111267 Completed Outcomes from Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease
111293 Completed A double blind, randomised, placebo controlled methodological cross-over study to investigate the senstivity of a novel study design and endpoints to treatment effects of naproxen in osteoarthritis
111294 Completed Analysis of the incidence of expression of tumor antigens in cancer tissue from patients with pathologically demonstrated bladder cancer
111295 Completed Immunogenicity and safety study of a GSK influenza vaccine candidate GSK 2115160A in adults. Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.